Original Article

Published: Jul 11, 2026 | DOI: 10.24911/amem.15-2828

Characteristics and clinical predictors of cardiogenic shock among patients presenting with acute ST-segment elevation myocardial infarction


Authors: Ahmed Aljizeeri , Nuwayyir Abdullah Alqasimi , Lujain Hatim Aljohani , Farah Mohammed Alharbi , Yazeed Abdullah Asery , Sultan Alnashmi Alqasim , Naif Khalid Alaqil , Mohamed Abdullah Albugami , Sultan Saleh Alotaibi , Talal Hussain Alharbi , Amjad Ahmed , Ihab Suliman


Abstract

Background: Cardiogenic shock (CS) is the leading cause of mortality in ST-segment elevation myocardial infarction (STEMI). Patients with acute coronary syndrome in Saudi Arabia present a decade younger than Western cohorts and have a higher diabetes burden, yet contemporary local data on CS are limited. We aimed to determine the incidence, characteristics, and predictors of CS in a Saudi STEMI cohort.
Methods: Single-center retrospective cohort study of consecutive adult patients with acute STEMI admitted to King Abdulaziz Cardiac Center, Riyadh, from January 2019 to December 2024. CS was defined by the SHOCK trial criteria. Univariate and multivariate logistic regression identified independent predictors.
Results: A total of 878 patients were included (mean age 57.2 ± 13.6 years; 86.6% male); 80 (9.1%) developed CS. Compared with patients without CS, those with CS had a higher prevalence of dyslipidemia (58.8% vs. 44.6%, p = 0.016) and ventricular arrhythmia (17.5% vs. 5.5%, p < 0.001), higher peak troponin and N-terminal pro-B-type natriuretic peptid, and lower hemoglobin, sodium, potassium, and estimated glomerular filtration rate. No differences were observed in age, sex, hypertension, diabetes, or infarct location. In multivariate analysis, independent predictors of CS were female sex odds ratio (OR 0.18, 95% confidence intervals 0.06-0.52), dyslipidemia (OR 2.39, 1.22-4.70), arrhythmia (OR 3.69, 1.63-8.37), peak troponin (p = 0.040), peak blood urea nitrogen (OR 1.05, 1.01-1.08), nadir hemoglobin (OR 0.97, 0.96-0.99), and nadir potassium (OR 0.16, 0.07-0.34).
Conclusion: CS occurred in 9.1% of this contemporary Saudi STEMI cohort. The predictors that emerged were not the classical Western ones; larger multicenter studies should confirm these findings and inform regional risk stratification.


Keywords: Cardiogenic shock, acute myocardial infarction, ST-segment elevation myocardial infarction, STEMI, Saudi Arabia, predictors.



Pubmed Style

Ahmed Aljizeeri, Nuwayyir Abdullah Alqasimi, Lujain Hatim Aljohani, Farah Mohammed Alharbi, Yazeed Abdullah Asery, Sultan Alnashmi Alqasim, Naif Khalid Alaqil, Mohamed Abdullah Albugami, Sultan Saleh Alotaibi, Talal Hussain Alharbi, Amjad Ahmed, Ihab Suliman. Characteristics and clinical predictors of cardiogenic shock among patients presenting with acute ST-segment elevation myocardial infarction. AMEM. 2026; 11 (July 2026): -. doi:10.24911/amem.15-2828

Publication History

Received: April 15, 2026

Revised: May 14, 2026 Revised: June 11, 2026

Accepted: June 21, 2026

Published: July 11, 2026


Authors

Ahmed Aljizeeri

King Abdulaziz Cardiac Center, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia.

Nuwayyir Abdullah Alqasimi

College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Lujain Hatim Aljohani

College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Farah Mohammed Alharbi

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Yazeed Abdullah Asery

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Sultan Alnashmi Alqasim

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Naif Khalid Alaqil

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Mohamed Abdullah Albugami

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Sultan Saleh Alotaibi

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Talal Hussain Alharbi

College of Medicine, Tabuk University, Tabuk, Saudi Arabia.

Amjad Ahmed

King Abdulaziz Cardiac Center, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia.

Ihab Suliman

King Abdulaziz Cardiac Center, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia.